FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Aortic Valve, Prosthesis, Percutaneously Delivered

PMA: P140031 · Supplement: S196 · Decision Dec 17, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P140031 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Aortic Valve, Prosthesis, Percutaneously Delivered
Trade Name
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (sizes 20mm, 23mm, 26mm) 9750TFX; Edwards SAPIEN 3 Ultra RESILIA Transc
PMA Number
P140031
Supplement Number
S196
Device Class
FDA Class 3
Product Code
NPT
Generic Name
Aortic valve, prosthesis, percutaneously delivered
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
December 17, 2025
Date Received
November 17, 2025
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

to implement a new sewing method for the attachment of the Main and paravalvular Skirts to the valve frame in certain valve models/sizes

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPT Aortic Valve, Prosthesis, Percutaneously Delivered